Bibliographic information
GuidelineGuideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
New
Oral PrEP (containing tenofovir disoproxil fumarate (TDF)) should be offered as an additional prevention choice for people at substantial risk of HIV infection as part of combination prevention approaches
Recommended in favor
Strong
Certainty of evidence
High